21 results on '"Low, Eric"'
Search Results
2. Estimated Burden of Screening for Barrett’s Esophagus in the United States
3. Development and Validation of a National US Achalasia Cohort: The Veterans Affairs Achalasia Cohort (VA-AC)
4. A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force
5. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
6. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial
7. The Surgical Clerkship and Medical Student Performance in a Standardized Patient Case of Acute Cholecystitis
8. A multidisciplinary personalised paradigm for achalasia
9. COMPARING DIAGNOSTIC METHODS TO MEASURE SPASTIC SEGMENT AND INFORM MYOTOMY LENGTH IN TYPE 3 ACHALASIA
10. COMPARING DIAGNOSTIC METHODS TO MEASURE SPASTIC SEGMENT AND INFORM MYOTOMY LENGTH IN TYPE 3 ACHALASIA
11. Mo1316 ASSESSING PANESOPHAGEAL PRESSURIZATION IN SUPINE AND UPRIGHT POSITIONS IN TYPE II ACHALASIA
12. Mo1309 IDENTIFYING SPASTIC VARIANT OF TYPE II ACHALASIA AFTER TREATMENT WITH HIGH-RESOLUTION MANOMETRY AND FLIP PANOMETRY
13. Mo1301 ESOPHAGEAL CIRCULAR MUSCLE THICKNESS ON ENDOSCOPIC ULTRASOUND ACROSS DISORDERS OF ESOPHAGOGASTRIC JUNCTION OUTFLOW
14. Sa1118 CHARACTERIZING DISEASE BURDEN AND RISK FACTORS IN LARYNGOPHARYNGEAL REFLUX DISEASE
15. 854 ESTIMATED BURDEN OF SCREENING FOR BARRETT'S ESOPHAGUS IN THE UNITED STATES
16. Dietary management of eosinophilic esophagitis
17. Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients
18. Patient Perception of Being Involved in a Clinical Trial for Multiple Myeloma Ceri Bygrave, Tanya Burton*, Patricia Carter, Sarah Richard, Eric Low, Charlotte Bloodworth
19. A Phase I Dose-Escalation Study of the Class 1 Selective Histone Deacetylase Inhibitor CHR-3996 in Combination with Tosedostat for Patients with Relapsed, Refractory Multiple Myeloma: Results of the Muk Three Trial
20. Carfilzomib, Cyclophosphamide and Dexamethasone Is Well Tolerated in Patients with Relapsed/Refractory Multiple Myeloma Who Have Received One Prior Regimen
21. A motorized grinder for making soil thin sections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.